The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Vulnerable Amino Acid May be Hepatitis C's Downfall

Back to News Homepage

Next

Inovio's HCV Vaccine Trial Delivers Good Results

Government Intervention Requested for Poor HCV Detection and Treatment

November 30, 2009

Print this page

Hepatitis C identification and care trends published in the December 2009 issue of Hepatology indicate a national, public health dilemma deserving of congressional action.

NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is ‘Wake-Up Call’ for Washington

WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ — New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today.

The NVHR warns that without congressional action, millions of Americans infected with chronic hepatitis C virus – particularly African Americans – are at serious risk of developing cirrhosis, liver cancer, and liver failure and will add billions of dollars in unnecessary costs to our health care system every year.

Continue reading the entire article:
http://www.prnewswire.com/news-releases/nvhr-new-data-finding-fewer-than-1-in-5-hepatitis-c-patients-receiving-antiviral-therapy-is-wake-up-call-for-washington-72130697.html

No Comments - be the first!
Share
Share

Previous

Vulnerable Amino Acid May be Hepatitis C's Downfall

Back to News Homepage

Next

Inovio's HCV Vaccine Trial Delivers Good Results

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.